Quite frankly I do not know. Probably not even the company knows as not sure it has ever been measured. I guess that is the point of the trial, to assess by how much Emricasan can reduce the MELD score and hence the probability of death within 3 months
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.